Second, our results demonstrate there is a correlation between the serum levels of CXCL9, CXCL10, and CXCL11 and the activity level of LN in SLE patients with concurrent LN, while it is not clear whether their abnormal levels are specifically caused by LN activity. Here, CXCL9 is linked to lobular neoplasia.